Merus N.V. Announces Proposed Public Offering of Common Shares
Merus N.V. Announces Proposed Public Offering of Common Shares GlobeNewswire June 03, 2025 UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics(R), Triclonics(R) and ADClonics(R)), today announced the launch […]